Skip to content
naulon

Not checkedNot checked for notices yet.

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children

Palang Chotsiri, Issaka Zongo, Paul Milligan and 10 more

Nature Communications · 2019

doi:10.1038/s41467-019-08297-9 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Seasonal malaria chemoprevention provides substantial benefit for young children, but resistance to used drugs will likely develop. Here, Chotsiri et al. evaluate the use of dihydroartemisinin-piperaquine as a regimen in 179 children, and population-based simulations suggest that small children would benefit from a higher and extended dosage.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.